ARS Pharmaceuticals
SPRY
SPRY
184 hedge funds and large institutions have $960M invested in ARS Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 58 increasing their positions, 54 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
184
Holders Change
+19
Holders Change %
+11.52%
% of All Funds
2.5%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.04%
New
41
Increased
58
Reduced
54
Closed
21
Calls
$2.67M
Puts
$4.54M
Net Calls
-$1.88M
Net Calls Change
-$910K
Top Buyers
Top Sellers
| 1 |
1
Alyeska Investment Group
Chicago,
Illinois
|
$3.65M |
| 2 |
2
State Street
Boston,
Massachusetts
|
$25.6M |
| 3 |
WP
3
Woodline Partners
San Francisco,
California
|
$7.55M |
| 4 |
4
UBS Group
Zurich,
Switzerland
|
$7.44M |
| 5 |
RA
5
Royce & Associates
New York
|
$8.09M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CIAM
201
Caitong International Asset Management
Hong Kong
| – | -$42.5K | -4,028 | Closed |
|
202
Federated Hermes
Pittsburgh,
Pennsylvania
| – | -$4.99K | -473 | Closed |
|
|
AP
203
Aspect Partners
Fairfax,
Virginia
| – | -$2.11K | -200 | Closed |
|
|
AWM
204
Avior Wealth Management
Omaha,
Nebraska
| – | -$527 | -50 | Closed |
|
|
EWA
205
EverSource Wealth Advisors
Birmingham,
Alabama
| – | -$53 | -5 | Closed |
|